Weill Cornell Medicine Enterprise Innovation x NCI SBIR

The Weill Cornell community can get insights on the latest NCI SBIR/STTR funding opportunities and commercialization resources for biotech innovators during a presentation on Wednesday, August 12.

NCI SBIR Program Directors Melissa Li and Julianne Twomey will provide detailed overview of how the SBIR/STTR program differs from traditional grant funding, discuss recent changes Congress made during the program’s reauthorization, and highlight what applicants need to know to prepare competitive proposals.

Learn more and register here.